594 related articles for article (PubMed ID: 19632706)
1. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
Manaster Y; Shenkman B; Rosenberg N; Savion N
Thromb Res; 2009 Sep; 124(4):477-82. PubMed ID: 19632706
[TBL] [Abstract][Full Text] [Related]
2. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the role of adjacent amino acids to the 313-320 sequence of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
Mitsios JV; Stamos G; Rodis FI; Tsironis LD; Stanica MR; Sakarellos C; Tsoukatos D; Tsikaris V; Tselepis AD
Platelets; 2006 Aug; 17(5):277-82. PubMed ID: 16928597
[TBL] [Abstract][Full Text] [Related]
4. Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries.
Schwarz M; Röttgen P; Takada Y; Le Gall F; Knackmuss S; Bassler N; Büttner C; Little M; Bode C; Peter K
FASEB J; 2004 Nov; 18(14):1704-6. PubMed ID: 15522915
[TBL] [Abstract][Full Text] [Related]
5. Integrin alphaIIbbeta3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation.
Chung J; Rader C; Popkov M; Hur YM; Kim HK; Lee YJ; Barbas CF
FASEB J; 2004 Feb; 18(2):361-3. PubMed ID: 14688205
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
[TBL] [Abstract][Full Text] [Related]
7. AFM imaging of ligand binding to platelet integrin alphaIIbbeta3 receptors reconstituted into planar lipid bilayers.
Hussain MA; Agnihotri A; Siedlecki CA
Langmuir; 2005 Jul; 21(15):6979-86. PubMed ID: 16008412
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
9. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
Morel-Kopp MC; Melchior C; Chen P; Ammerlaan W; Lecompte T; Kaplan C; Kieffer N
Thromb Haemost; 2001 Dec; 86(6):1425-34. PubMed ID: 11776310
[TBL] [Abstract][Full Text] [Related]
10. Construction of drug screening cell model and application to new compounds inhibiting FITC-fibrinogen binding to CHO cells expressing human alphaIIbbeta3.
Yang J; Yao J; Chen J; Wang XN; Zhu TY; Chen LL; Chu P
Eur J Pharmacol; 2009 Sep; 618(1-3):1-8. PubMed ID: 19619528
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody.
Bergmeier W; Schulte V; Brockhoff G; Bier U; Zirngibl H; Nieswandt B
Cytometry; 2002 Jun; 48(2):80-6. PubMed ID: 12116368
[TBL] [Abstract][Full Text] [Related]
12. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
13. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor.
Fitzgerald JR; Loughman A; Keane F; Brennan M; Knobel M; Higgins J; Visai L; Speziale P; Cox D; Foster TJ
Mol Microbiol; 2006 Jan; 59(1):212-30. PubMed ID: 16359330
[TBL] [Abstract][Full Text] [Related]
14. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
Chiang TM; Zhu J
Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
Wittig K; Rothe G; Schmitz G
Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
[TBL] [Abstract][Full Text] [Related]
16. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function.
Law DA; DeGuzman FR; Heiser P; Ministri-Madrid K; Killeen N; Phillips DR
Nature; 1999 Oct; 401(6755):808-11. PubMed ID: 10548108
[TBL] [Abstract][Full Text] [Related]
17. Activation of individual alphaIIbbeta3 integrin molecules by disruption of transmembrane domain interactions in the absence of clustering.
Litvinov RI; Vilaire G; Li W; DeGrado WF; Weisel JW; Bennett JS
Biochemistry; 2006 Apr; 45(15):4957-64. PubMed ID: 16605263
[TBL] [Abstract][Full Text] [Related]
18. Protein disulphide isomerase in platelet function.
Manickam N; Sun X; Li M; Gazitt Y; Essex DW
Br J Haematol; 2008 Jan; 140(2):223-9. PubMed ID: 18028487
[TBL] [Abstract][Full Text] [Related]
19. Heparin modulates integrin function in human platelets.
Sobel M; Fish WR; Toma N; Luo S; Bird K; Mori K; Kusumoto S; Blystone SD; Suda Y
J Vasc Surg; 2001 Mar; 33(3):587-94. PubMed ID: 11241131
[TBL] [Abstract][Full Text] [Related]
20. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets.
Peerschke EI
Thromb Haemost; 1995 May; 73(5):862-7. PubMed ID: 7482417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
